Industry
New funding boosts development of microbiome-based therapies for hereditary cancer risk, opening paths to alternatives beyond surgery.
The Bill & Melinda Gates Foundation accelerates research and innovation targeting the most neglected areas of female health.
With a strategic loan from the European Investment Bank, the French biotech doubles down on its mission to bring microbiome ecosystem therapies to market for patients battling blood cancers.
A unique partnership between Yakult and Nature Portfolio to build a global community of microbiome pioneers.
Industry
Sponsored by
dsm-firmenich Italy successfully hosts its first exclusive event on biotics.
Xervyteg® marks a major advance in microbiome therapeutics, with potential to become the first approved microbiota therapy in Europe.
Industry, Video
Sponsored by
Carlo Sala, Sales Director EMEA & LATAM - Microbiome BU at Sacco System, discusses the company innovative probiotic strains, tailored manufacturing services, and commitment to R&D.
Danone has announced the acquisition of The Akkermansia Company (TAC), significantly expanding its investment into gut health and next-generation biotic research.
Industry
Sponsored by
An interview to SynBalance Marketing Manager, Silva Castegnaro on the latest clinically backed solutions shaping the future of biotics world.
With nearly half of European consumers taking supplements for general wellbeing, the potential for targeted innovation is vast, especially on “biotics” products.
